Medical Device News Magazine

JVIR, SIR Foundation Honor Best Research Published in 2019

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Journal of Vascular and Interventional Radiology (JVIR)—the Society of Interventional Radiology’s (SIR’s) peer-reviewed scientific journal—announced the 2019 JVIR Editor’s Best awards in the May issue of the journal, published online today. The annual awards, supported by SIR Foundation, were chosen by the editor after a comprehensive editorial board review of all papers submitted to JVIR during the prior year.

2019 JVIR EDITOR’S AWARD FOR OUTSTANDING CLINICAL STUDY

Belinda A. Mohr, Ph.D., was honored with the award for outstanding clinical research paper for “Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial.”

In citing why this paper stood out, JVIR Editor-in-chief Ziv J Haskal, M.D., FSIR, said, “The analysis adds to the growing base of rigorous economic assessments of our interventional therapies. Hemodialysis costs billions of dollars in America. Our growing number of prospective controlled IR-led trials, such as in end-stage renal disease, allow this very type of essential research to help define the societal value of interventions for our patients.”

2019 JVIR EDITOR’S AWARD FOR OUTSTANDING LABORATORY INVESTIGATION

Yuchen Huo, MA, of the University of California San Diego, was honored with the award for outstanding laboratory investigation for “Stress Conditions Induced by Locoregional Therapies Stimulate Enrichment and Proliferation of Liver Cancer Stem Cells.”

“The downstream immunologic effects of thermal and transcatheter oncological treatments are being methodically fleshed out in the IR literature,” said Haskal. “One aspect is the under-recognized potential stimulatory effect of locoregional HCC treatments which might risk promulgating HCC stem cell proliferation, lessening overall cancer outcomes. This study described and quantified this very effect and defined a pathway for potentially suppressing it.”

Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville, also recognized the authors of an additional 12 clinical and five laboratory papers for their contributions. “In my decade as editor, this year marked a remarkably rich and diverse one for interventional radiologic research,” noted Haskal.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”